farnesol has been researched along with zoledronic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrich, F; Berger, W; Elbling, L; Heffeter, P; Kotz, R; Kubista, B; Micksche, M; Scotlandi, K; Sevelda, F; Sutterlüty, H; Toma, C; Trieb, K | 1 |
| Bieler, G; Hasmim, M; Rüegg, C | 1 |
| Auriola, S; Mönkkönen, H; Mönkkönen, J; Räikkönen, J | 1 |
| Coates, DE; Cullinan, MP; Drummond, BK; Milne, T; Seymour, GJ; Zafar, S | 1 |
| Hagelauer, N; Pabst, AM; Walter, C; Ziebart, T | 1 |
| Hiroshima, K; Jiang, Y; Kawamura, K; Kobayashi, H; Okamoto, S; Sekine, I; Shimada, H; Shingyoji, M; Tada, Y; Tagawa, M; Takiguchi, Y; Tatsumi, K | 1 |
| Ikebe, T; Kajiya, H; Nagaoka, Y; Okabe, K; Ozeki, S | 1 |
| Cheng, HL; Hsieh, MJ; Lin, CW; Lu, KH; Yang, JS; Yang, SF | 1 |
8 other study(ies) available for farnesol and zoledronic acid
| Article | Year |
|---|---|
Anticancer effects of zoledronic acid against human osteosarcoma cells.
Topics: Actin Cytoskeleton; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Density Conservation Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cyclin D; Cyclin E; Cyclins; Diphosphonates; DNA; DNA Replication; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Farnesol; Humans; Imidazoles; Osteosarcoma; Protein Prenylation; Terpenes; Zoledronic Acid | 2006 |
Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Topics: Angiogenesis Inhibitors; Bone Density Conservation Agents; Cell Adhesion; Cell Movement; Cell Survival; Cells, Cultured; Diphosphonates; Diterpenes; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Farnesol; Focal Adhesion Kinase 1; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Phosphorylation; Protein Kinase Inhibitors; Protein Prenylation; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins c-akt; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Tumor Necrosis Factor-alpha; Umbilical Veins; Zoledronic Acid | 2007 |
Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Topics: Adenosine Triphosphate; Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Down-Regulation; Drug Screening Assays, Antitumor; Farnesol; Female; Gene Expression Regulation, Neoplastic; Hemiterpenes; Humans; Imidazoles; Mevalonic Acid; Organophosphorus Compounds; Zoledronic Acid | 2010 |
Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
Topics: Adult; Apoptosis; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Cell Culture Techniques; Cell Survival; Cells, Cultured; Diphosphonates; Diterpenes; Epiregulin; Farnesol; Female; Fibroblasts; Gene Expression Regulation; Gingiva; Humans; Imidazoles; Interferon-alpha; Mevalonic Acid; Microscopy, Electron, Transmission; Middle Aged; Neovascularization, Physiologic; Polyisoprenyl Phosphates; rhoB GTP-Binding Protein; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2014 |
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Movement; Cell Survival; Cells, Cultured; Cyclohexenes; Diphosphonates; Diterpenes; Endothelial Cells; Eugenol; Farnesol; Fibroblasts; Humans; Imidazoles; Limonene; Menthol; Osteogenesis; Protein Prenylation; Recurrence; Squalene; Terpenes; Umbilical Veins; Zoledronic Acid | 2015 |
Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Topics: Apoptosis; cdc42 GTP-Binding Protein; Cell Line, Tumor; Diphosphonates; Diterpenes; DNA Topoisomerases, Type II; Farnesol; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Leucine; Mesothelioma; Myeloid Cell Leukemia Sequence 1 Protein; Protein Prenylation; rab GTP-Binding Proteins; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; RNA, Small Interfering; S Phase; Signal Transduction; Transferases; Zoledronic Acid | 2014 |
Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
Topics: Acid Phosphatase; Adaptor Proteins, Signal Transducing; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Remodeling; Calcification, Physiologic; Cathepsin K; Cell Differentiation; Cells, Cultured; Diphosphonates; Diterpenes; Farnesol; Imidazoles; Isoenzymes; Lipopolysaccharides; Macrophages; Male; Maxilla; Membrane Proteins; Mevalonic Acid; Mice; Mice, Inbred C57BL; Osteoclasts; Polyisoprenyl Phosphates; Receptors, Calcitonin; Salmonella; Tartrate-Resistant Acid Phosphatase; Tooth Socket; Vacuolar Proton-Translocating ATPases; Zoledronic Acid | 2015 |
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
Topics: Biological Transport; Bone Density Conservation Agents; Bone Neoplasms; Cadherins; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Cell Survival; Diphosphonates; Diterpenes; Epithelial-Mesenchymal Transition; Farnesol; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Neoplasm Invasiveness; Nuclear Proteins; Osteoporosis; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prenylation; Proto-Oncogene Proteins pp60(c-src); rho-Associated Kinases; Snail Family Transcription Factors; Twist-Related Protein 1; Zoledronic Acid | 2016 |